# About CJC-1295 Ipamorelin: The Editorial Behind CJC Ipa Source

> About CJC-1295 Ipamorelin coverage at CJC Ipa Source — an independent editorial project summarizing the peer-reviewed literature. Not a clinic, not a vendor, not a prescription.

Who keeps this reading room, and what 'source' does — and does not — mean here.

## What this site is

CJC Ipa Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295 Ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built around a single lens — sleep — because that is where the mechanism and the human reports most clearly meet: growth hormone crests in deep sleep, and the ghrelin arm of this pairing has a documented hand in slow-wave depth. The mythic-poetic framing of an aurora after dark is a way of reading the literature, not a claim about effects. Under the poetry, every quantitative statement is cited, and the central honesty — that the fixed combination has never been tested in a controlled trial — is kept in plain sight on every relevant page.

## What 'source' means here

The word 'source' in this domain name is editorial framing, not a claim of services. It names the position this publisher occupies relative to the literature — a place you come to find the sourced studies and what they actually say — not a place that sources, supplies, sells, or ships anything. We do not source, sell, or broker any peptide, and there is nothing for sale here.

The distinction matters, so we state it plainly: a 'source' of *information* is what this is; a vendor is what it is not. The modifier sets a tone for how the research is gathered and presented, and nothing more. No products, no transactions, no inventory, no prescriptions pass through this site.

## How we handle the evidence

We lead with what was measured and attribute it to the study, by species and route, every time. We separate three things and never let them blur: what controlled studies established for each single component; what is reasonably inferred from general GHRH-plus-GHRP synergy work using related peptides; and what people in research-use communities merely report, which we label as anecdotal. We carry no human dosing recommendations and use only generic compound names. Where the literature is silent — most sharply, on the fixed blend itself — we say so rather than fill the gap. That discipline, not the aurora, is what makes this a research digest.

---

A nightfall reading of the CJC-1295 and ipamorelin literature — the aurora is wonder, the steel is rigor, and nothing here is a clinic, a prescription, or a thing for sale.